Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine
Clinical trial NCT00323622 · COMPLETED
Trial details
- NCT number
- NCT00323622
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2007-05-01
- Enrollment
- 1737
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.